# Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference Canonical URL: https://biopharmsignal.com/news/PSNL/personalis-to-participate-in-the-td-cowen-46th-annual-healthcare-conference Ticker: PSNL Company: Personalis Source: Personalis Published: 2026-02-17 21:01 EST Original Source URL: https://investors.personalis.com ## Summary FREMONT, Calif. --(BUSINESS WIRE)--Feb. 17, 2026-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the   TD Cowen 46 th Annual Healthcare Conference on Tuesday, March 3, 2026 at the Boston Marriott ## Article Body FREMONT, Calif. --(BUSINESS WIRE)--Feb. 17, 2026-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the TD Cowen 46 th Annual Healthcare Conference on Tuesday, March 3, 2026 at the Boston Marriott ## Recent Company News - 2026-06-02 10:00 EST — [Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026](https://biopharmsignal.com/news/PSNL/personalis-highlights-early-colorectal-cancer-recurrence-detection-and-ultrasensitive-mrd-performance-across-a-broad-set-of-tumor-types-at-asco-2026) — Source: Personalis - 2026-05-26 10:00 EST — [Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium](https://biopharmsignal.com/news/PSNL/personalis-to-highlight-breadth-of-next-personalr-ultra-sensitive-ctdna-data-at-asco-2026-annual-meeting-including-podium-presentation-from-tracerx-consortium) — Source: Personalis - 2026-05-20 10:00 EST — [Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring](https://biopharmsignal.com/news/PSNL/personalis-secures-fourth-medicare-coverage-decision-for-next-personalr-expanding-breast-cancer-coverage-to-pre-surgical-treatment-monitoring) — Source: Personalis - 2026-05-14 20:01 EST — [Personalis to Participate in Upcoming Investor Events](https://biopharmsignal.com/news/PSNL/personalis-to-participate-in-upcoming-investor-events) — Source: Personalis - 2026-05-13 10:00 EST — [Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors](https://biopharmsignal.com/news/PSNL/personalis-receives-medicare-coverage-for-next-personalr-for-immunotherapy-monitoring-across-late-stage-solid-tumors) — Source: Personalis ## Related News - 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9) - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)